Ads
related to: prostate cancer, cell- nmCRPC Treatment Option
31% Risk of Death Decrease
Visit The Patient Site.
- Dosing & Administration
View Recommended Dosage & Learn
About Drug Interactions Here.
- Clinical Information
Read About A Double-Blind, Placebo-
Controlled, Randomized Study.
- Downloadable Resources
Resources For Physicians & Patients
Available On The Site To Download.
- nmCRPC Treatment Option
Search results
Researchers discover vaccine originally created for HIV may also combat cancer
Medical Xpress· 5 days agoCytomegalovirus, or CMV, is a common virus that infects most people in their lifetimes and typically...
Six cancer treatment breakthroughs pushing us closer to a cure
The Telegraph via Yahoo News· 4 days agoWhat will it treat? PCNA is found in all cancers, and AOH1996 has shown promise in 70 cell lines,...
Is BPA Making You Sick?
Mercola· 6 days agoFirst created in 1891 by a Russian chemist, BPA didn't make an appearance in the manufacture of products until the 1950s, when it was used to produce resilient, and often transparent plastics ...
Breakthrough bowel cancer drug 'could triple survival chances' for patients
Daily Express· 1 day agoA blockbuster drug could triple survival chances for some bowel cancer patients by “melting away”...
Candel (CADL) Stock Skyrockets 431% Year to Date: Here's Why
Zacks via Yahoo Finance· 6 days agoCandel (CADL) surges 431% in the year-to-date period, driven by positive developmental and...
Cancer can be caused by reversible molecular changes, study shows
Medical Xpress· 4 days agoThis theory posits that DNA mutations are the primary cause of cancers. It's well known that aging,...
AI cancer screening programs are booming, but you'll likely have to pay for them yourself
CNBC· 4 days agoThe FDA has approved nearly 600 radiology AI program since 2019, but most aren't covered by Medicare...
AMGEN TO PRESENT INNOVATIVE RESEARCH FROM ITS ROBUST ONCOLOGY PORTFOLIO AT ASCO 2024
Morningstar· 6 days agoData From Newly FDA-Approved IMDELLTRA™ (tarlatamab-dlle) Further Reinforce Leadership in Bispecific T-Cell Engagers Overall Survival Data from Phase 3 LUMAKRAS® (sotorasib ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 7 days agoCortechs.ai, a market leader in the quantitative imaging space for over a decade with their flagship product NeuroQuant, is now formally expanding beyond neuroradiology with the widespread commercialization ...
AI cancer screening programs are booming, but you'll likely have to pay for them yourself
NBC Miami· 4 days agoThe FDA has approved nearly 600 radiology artificial intelligence and machine learning programs and...